Researchers closer to developing meningitis B vaccine

NewsGuard 100/100 Score
Jul 18 2011

"New research may bring scientists one step closer to developing a vaccine that protects against hundreds of strains of meningococcus B, the most common cause of bacterial meningitis," according to research published last week in Science Translational Medicine, HealthDay News reports. Researchers used methods that allowed them to identify the most effective vaccine candidate, technology that could be used to develop vaccines for malaria and AIDS, the news service notes (7/15).

"Vaccines against some strains of meningitis have been used for decades, but the method for creating them was not effective in developing a vaccine against the most common variety of the meningitis bacteria, called group B," VOA News writes (Chimes, 7/15).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Medical Research News | Disease/Infection News

    Tags: , , , , , , , , ,

    Comments (1)

    Suggested Reading

    Novel vaccine approach targets AML and other blood cancers
    Study shows potential for universal flu vaccine with broad antibody response
    New monoclonal antibody vaccine slashes malaria risk in children
    Equal vaccination rates found among undocumented Latinx ER patients in the U.S.
    Bivalent COVID-19 vaccine boosts immunity but needs to be updated
    Researchers identify key barriers and outline recommendations for vaccine uptake in pregnant women
    MSU team creates a promising vaccine candidate for antibiotic-resistant bacteria
    New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses

    Comments

    1. Researchers closer to developing meningitis B vaccine
      Caroline Petrie Caroline Petrie United States says:
      July 18, 2011 at 5:28 PM

      The Meningitis Foundation of America (MFA), a national organization, would like the public & media to know that information is available regarding the diagnosis, treatment & prevention of meningitis. MFA was founded in 1997 by parents whose children were affected by meningitis. In addition to supporting vaccination & preventing meningitis, the MFA provides information to educate the public & medical professionals so that the early diagnosis, treatment &, most important, prevention of meningitis, will save lives. Meningitis is a dangerous & often times fatal inflammation of the brain &/or spinal cord that can leave survivors with serious life-long physical problems MFA would like to be considered as a news resource for the disease. For further information, visit the MFA website at www.musa.org.

      Thank you,
      MFA
      Box 1818
      El Mirage AZ  85335
      480 270 2652
      World Meningitis Day 24 April 2011

      Reply
    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    The path to a better tuberculosis vaccine runs through Montana